Veranes-Mustelier Y, Besse-Díaz R, Martínez-Cantillo L, Olivares-Álvarez DR, Galera-Fernández CN

Language: Spanish
References: 19
Page: 1-13
PDF size: 724.50 Kb.

ABSTRACT

Introduction: Ending 2019, the first reported cases of Covid-19 broke out in Wuhan, China. This disease may affect directly the cardiovascular system or predispose it to be infected by the SARS-CoV-2.
Objective: To identify the cardiometabolic predictive factors for mortality in patients with SARS-CoV-2/COVID-19 from Santiago de Cuba city in the period May 2020 throughout May 2021.
Method: An analytical cohort study was carried out. It was a co-operative research that involved professionals from the Internal Medicine and Intensive Care Services at the Hospital Clínico Quirúrgico “Ambrosio Grillo Portuondo”, as well as professionals from the Dirección Municipal de Salud in Santiago de Cuba city. A sample of 120 patients was selected for the identification of cardiometabolic predictive factors for mortality. Data analysis was based on the performance of a multivariate model (multivariate logistic regression).
Results: Throughout the hospitalization period 15 diseases were reported. Female sex was predominant but statistically we can´t associate to the deaths these two gender variables. However, age over 60 years, the arterial hypertension, diabetes mellitus and, in a high rank, the vascular involvement, were observed in a strongly association with mortality (p=0.0001).
Conclusions: This research allowed the identification of cardiometabolic predictive factors for mortality in COVID-19, where age over 60 years, vascular involvement (cardiogenic shock), hypertension and diabetes mellitus are the main causal factors in the pathophysiological and statistical explanation of mortality.

REFERENCES

1. Huang C, Wang Y, Li X, Lili R, Jianping Z, Yi H, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 [citado 24/11/2021]; 395:497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

2. OMS. Rolling updates on coronavirus disease (COVID-19) Rolling updates on coronavirus disease (COVID-19). www.who.int. 2019 [citado 19/06/2021]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2 019/events-as-they-happen

3. Peretto G, Sala S, Rizzo S, Luca G de, Campochiaro C, Sartorelli S, Thiene G. Arrhythmias in myocarditis: state of the art. Heart Rhythm. 2019; 16(5): 793-801.

4. Peretto G, Sala S, Rizzo S, Palmisano A, Esposito A, Cobelli F de, Thiene G. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J Am Coll Cardiol [Internet]. 2020 [citado 19/06/2021]; 75(9): 1046-1057. DOI: https://doi.org/10.1016/j.jacc.2020.01.036

5. Pis Guirola C, Pérez Muñoa D. Comorbilidades y COVID-19 en Cuba: el desafío de las enfermedades asociadas. www.acn.cu. [citado 19/06/2021]. Disponible en: http://www.acn.cu/salud/76429-comorbilidades-y-covid-19-en-cuba-el-desafio-de-las-enfermedades-asociadas

6. Martínez Hernández L. Lo afirman los expertos: Pronósticos de la COVID-19 en Cuba son desfavorables. Trabajadores. 27 Abr 2021. Disponible en: http://www.trabajadores.cu/20210427/lo-afirman-los-expertos-pronosticos-de-la-covid-19-en-cuba-son-desfavorables/

7. Bandera Jiménez DC, Morandeira Padrón H, Valdés García LE, Rodríguez Valdés A, Sagaró del Campo N, Palú Orozco A, et al. Morbilidad por COVID-19: análisis de los aspectos epidemiológicos, clínicos y diagnósticos. Rev Cubana Med Trop [Internet]. 2020 Dic [citado 19/06/2021]; 72(3):e574. Disponible en: http://scielo.sld.cu/scielo.php?script=sciarttext&pid=S0375-0760 2020000300005&lng=es

8. Martínez Hernández L. Ante la COVID-19 Santiago de Cuba no se puede cansar. Granma. 18 06 2021. Disponible en: http://www.granma.cu/cuba-covid-19/2021-06-18/hace-falta-exigencia-hace-falta-rigo r-en-santiago-de-cuba-frente-a-la-pandemia-18-06-2021-00-06-04

9. González Tabares R, Acosta González FA, Oliva Villa E, Rodríguez Reyes SF, Cabeza Echevarría I. Predictores de mal pronóstico en pacientes con la COVID-19. Rev Cubana Med Mil [Internet]. 2020 Dic [citado 21/06/2021]; 49(4):e918. Disponible en: http://scielo.sld.cu/scielo.php?scri pt=sciarttext&pid=S0138-65572020000400020&lng=es

10. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA [Internet]. 2020 [citado 21/06/2021]; 323(20):2052-9. DOI: https://doi.org/10.1001/jama.2020.6775

11. Zapata - Mercado JA, Gallegos - Pérez IA, Zapata - Mercado CI. Una revisión sobre factores clínicos y pronóstico en pacientes con diabetes mellitus infectados por el SARS-CoV-2. Rev 16 de Abril [Internet]. 2020 [citado 21/06/2021]; 59(278):e1015. Disponible en: http://www.rev16deabril.sld.cu/index.php/16_4/article/view/1015

12. Salazar M, Barochiner J, Espeche W, Ennis I. COVID-19, hipertensión y enfermedad cardiovascular. Hipertens Riesgo Vasc [Internet]. 2020 Oct-Dec [citado 21/06/2021]; 37(4):176-180. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301092/

13. Plasencia-Urizarri TM, Aguilera-Rodríguez R, Almaguer-Mederos LE. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Rev Hab Cienc Méd [Internet]. 2020 [citado 21/06/2021]; 19(Suppl1):e3389. Disponible en: http://scielo.sld.cu/scielo.php?script=sciarttext&pid=S1729-519 X2020000400002&lng=es

14. Franco VD, Morales Chorro L, Baltrons Orellana R, Rodríguez Salmerón CR, Urbina O, López de Blanco C. Mortalidad por COVID-19 asociada a comorbilidades en pacientes del Instituto Salvadoreño del Seguro Social. Alerta [Internet]. 2021 [citado 21/11/2021]; 4(2). DOI: https://doi.org/10.5377/alerta.v4i2.10366

15. Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endo [Internet] 2020 [citado 20/09/2021]; 8(10):813-22. Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30272-2/fulltext

16. Liu Z, Li J, Huang J, Guo L, Gao R, Luo K, et al. Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan. Front Endocrinol [Internet]. 2020 [citado 20/09/2021]; 11:478. Disponible en: https://www.frontiersin.org/articles/10.3389 /fendo.2020.00478/full

17. Pettit NN, MacKenzie EL, Ridgway JP, Pursell K, Ash D, Patel B, Pho MT. La obesidad se asocia con un mayor riesgo de mortalidad entre los pacientes hospitalizados con COVID-19. Obesity [Internet]. 2020 Oct [citado 25/08/2021]; 28(10):1806-1810. Disponible en: https://www.google.com/search?client=firefox-b-

18. Yang J, Hu J, Zhu C. La obesidad agrava el COVID-19: una revisión sistemática y un metaanálisis. J Med Virol [Internet]. 2020 Jul [26/06/2020]; 93:257-268. Disponible en: https://www.intramed.net/contenidover.asp?contenidoid=96384

19. Lozano Gómez H, Pascual Bielsa A, Arche Banzo MJ. Miocarditis fulminante y shock cardiogénico en el curso de infección por SARS-CoV-2. Med Clin (Barc) [Internet]. 2020 Nov [citado 20/09/2021]; 155(10):463-464. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386607/